^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    theralizumab (TAB08)

    i
    Other names: TAB08, TGN1412
    Associations
    News
    Trials
    Company:
    TheraMab
    Drug class:
    CD28 superagonist
    Associations
    News
    Trials